We are live on
!
Find out more
HAG
HighPoint Advisor Group Portfolio holdings
AUM
$2.84B
1-Year Est. Return
31.94%
This Fund
S&P 500
This Quarter
Est. Return
-11.2%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$12.4M
(+3.4%)
Cap. Flow
+$26.4M
Cap. Flow
% of AUM
6.98%
Top 10 Holdings %
Top 10 Hldgs %
27%
Holding
388
New
36
Increased
167
Reduced
112
Closed
67
Avg Time Held
8
quarters
Top 10 Avg Time Held
8.2
quarters
Top 20 Avg Time Held
7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$10.5M |
| 2 |
Walmart Inc
WMT
|
+$6.77M |
| 3 |
Apple
AAPL
|
+$5.34M |
| 4 |
Coca-Cola Consolidated
COKE
|
+$4.47M |
| 5 |
W.P. Carey
WPC
|
+$4.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walgreens Boots Alliance
WBA
|
+$8.31M |
| 2 |
Verizon
VZ
|
+$3.97M |
| 3 |
CCT
Corporate Capital Trust, Inc.
CCT
|
+$2.39M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.75M |
| 5 |
COL
Rockwell Collins
COL
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.27% |
| 2 | Consumer Staples | 13.47% |
| 3 | Healthcare | 12.5% |
| 4 | Financials | 12.33% |
| 5 | Industrials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Hewlett Packard
HPE
$97.5B
| $244K | 0.06% |
+15,184
| New | +$227K |
2018 Q4
0 quarters
|
|
252
O'Reilly Automotive
ORLY
$69.9B
| $244K | 0.06% |
9,540
+1,605
| +20% | +$36.5K |
2018 Q3
1 quarter
|
|
|
AGN
253
DELISTED
Allergan plc
AGN
| $244K | 0.06% |
1,774
+125
| +8% | +$20.5K |
2018 Q1
3 quarters
|
|
254
Ameriprise Financial
AMP
$44.2B
| $242K | 0.06% |
1,859
-435
| -19% | -$54.6K |
2016 Q3
9 quarters
|
|
255
Stryker
SYK
$106B
| $242K | 0.06% |
+1,301
| New | +$218K |
2018 Q4
0 quarters
|
|
256
Quest Diagnostics
DGX
$25.5B
| $240K | 0.06% |
2,727
+734
| +37% | +$68.8K |
2018 Q1
3 quarters
|
|
257
Zoetis
ZTS
$30.9B
| $240K | 0.06% |
2,532
+81
| +3% | +$7.29K |
2018 Q1
3 quarters
|
|
258
Cummins
CMI
$72.1B
| $238K | 0.06% |
1,553
-205
| -12% | -$28.9K |
2016 Q1
11 quarters
|
|
259
Marriott International
MAR
$95.4B
| $231K | 0.06% |
1,900
-840
| -31% | -$96.4K |
2017 Q1
7 quarters
|
|
260
Bank of New York Mellon
BNY
$96.8B
| $229K | 0.06% |
4,339
+285
| +7% | +$13.8K |
2017 Q4
4 quarters
|
|
261
State Street
STT
$48.1B
| $228K | 0.06% |
3,207
+69
| +2% | +$4.94K |
2017 Q4
4 quarters
|
|
262
AstraZeneca
AZN
$247B
| $227K | 0.06% |
2,810
-800
| -22% | -$62.5K |
2015 Q4
12 quarters
|
|
263
Cracker Barrel
CBRL
$1.28B
| $227K | 0.06% |
1,322
-53
| -4% | -$8.71K |
2017 Q4
4 quarters
|
|
264
Entergy
ETR
$49.1B
| $226K | 0.06% |
5,030
+72
| +1% | +$3.06K |
2018 Q2
2 quarters
|
|
|
ONCE
265
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $224K | 0.06% |
4,390
-2,300
| -34% | -$99.8K |
2017 Q4
4 quarters
|
|
266
Cognizant
CTSH
$26.7B
| $217K | 0.06% |
2,970
+506
| +21% | +$35.2K |
2018 Q1
3 quarters
|
|
267
Kroger
KR
$36.4B
| $215K | 0.06% |
7,290
-265
| -4% | -$7.69K |
2015 Q4
12 quarters
|
|
268
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $214K | 0.06% |
11,885
+1,153
| +11% | +$23.6K |
2018 Q3
1 quarter
|
|
269
British American Tobacco
BTI
$119B
| $213K | 0.06% |
+5,836
| New | +$227K |
2018 Q4
0 quarters
|
|
270
Takeda Pharmaceutical
TAK
$59.8B
| $213K | 0.06% |
+10,563
| New | +$178K |
2018 Q4
0 quarters
|
|
271
Ally Financial
ALLY
$11.4B
| $211K | 0.06% |
+7,783
| New | +$195K |
2018 Q4
0 quarters
|
|
|
CVIA
272
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $209K | 0.06% |
42,089
+9,999
| +31% | +$60.2K |
2018 Q2
2 quarters
|
|
273
Dollar General
DG
$28.1B
| $208K | 0.06% |
1,751
+176
| +11% | +$19.1K |
2018 Q3
1 quarter
|
|
274
Fidelity National Information Services
FIS
$17.6B
| $208K | 0.06% |
1,921
+73
| +4% | +$7.61K |
2018 Q3
1 quarter
|
|
|
CHL
275
DELISTED
China Mobile Limited
CHL
| $206K | 0.05% |
3,918
-418
| -10% | -$20.1K |
2018 Q3
1 quarter
|
|
Similar funds
FMC
ORCP
PCIG
DIG
BDLIB
EMFAT
WGI
RL
HighPoint Advisor Group's Q4 2018 Portfolio in Review
As of Q4 2018, HighPoint Advisor Group held 388 positions worth $378M, up 3.4% from $365M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
HighPoint Advisor Group deployed $26.4M of net new capital in Q4 2018, opening 36 new positions and adding to 167 existing holdings. Its largest new stake was Xilinx Inc: 48,952 shares worth $932K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $8.31M trimmed.
- HighPoint Advisor Group's largest Q4 2018 buy was Xilinx Inc: 48,952 shares worth $932K.
- HighPoint Advisor Group added most to Visa in Q4 2018, an estimated $10.5M increase.
- HighPoint Advisor Group's biggest Q4 2018 reduction was Walgreens Boots Alliance, cutting an estimated $8.31M.
- HighPoint Advisor Group fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $2.39M.
- HighPoint Advisor Group's ten largest holdings make up 27% of its $378M portfolio in Q4 2018.
- HighPoint Advisor Group opened 36 new positions and closed 67 in Q4 2018.
- HighPoint Advisor Group's portfolio value rose 3.4% quarter-over-quarter to $378M.
Based on HighPoint Advisor Group's 13F filing for Q4 2018, filed 20 Feb 2019.